Funding Received
$24 Million in 5 Rounds from 4 Investors
Most Recent Funding
$10 Million Series C on October 30, 2013
Founded:
1997
Headquarters:
Woburn, MA
Description:
PathoGenetiX offers an automated system for the rapid identification of pathogenic bacterial strains using its proprietary technology.
Founders:
Jens Kurth
Categories:
Biotechnology
Website:
http://pathogenetix.com

Detailed Description

Update

PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with initial commercial introduction into the research market planned for 2012.

Current Team (4)

Update

Past Team (3)

Update

Board Members and Advisors (5)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    12 Gill Street

    Suite 2150

    Woburn, MA 01801

    USA

Images (1)

Update
  • C680fc47b2f686ae7cd1b08584910ead